# A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

> **NCT04618744** · PHASE2 · COMPLETED · sponsor: **Oramed, Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** ORMD-0801 (Insulin) capsule 8 mg BD
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04618744
- **Lead sponsor:** Oramed, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-24
- **Primary completion:** 2022-06-27
- **Final completion:** 2022-06-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04618744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04618744, "A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04618744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*